abstract |
The present invention relates to a composition for the prevention or treatment of neurodegenerative diseases using CD9, and a method for screening a therapeutic agent for neurodegenerative diseases and, more specifically, to a pharmaceutical composition for the prevention or treatment of neurodegenerative diseases comprising, as an active ingredient, an inhibitor against the expression or activity of CD9 protein, and a method for screening a therapeutic agent for neurodegenerative diseases. A material for inhibiting the expression or activity of CD9 exhibits the effect of improving the memory of patients with neurodegenerative diseases, and thus can be effectively used in the development of a therapeutic agent for neurodegenerative diseases, and through assay of the expression level of CD9, candidate materials for the therapeutic agent for neurodegenerative diseases can be screened. |